DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)

MANUFACTURER: Sanofi – Aventis Groupe

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medicines & Healthcare products Regulatory Agency (MHRA)

Medsafe (NZ)

It is a prescription drug used in the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord, resulting in muscle weakness, loss of motor function, and, ultimately, paralysis.